Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Maculopathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05403749
What this trial is testing

Longer Interval of IVT IBI302 in Subjects With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 132
Early research (Phase 1)Study completedNCT06213038
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Youxin Chen 12
Not applicableWithdrawnNCT04045704
What this trial is testing

Cataract Surgery on Advanced Age Related Macular Degeneration Patients

Who this might be right for
CataractMacular Degeneration Advanced
University of British Columbia
Not applicableStudy completedNCT03939767
What this trial is testing

Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 1,563
Large-scale testing (Phase 3)Study completedNCT00056836
What this trial is testing

Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration

Who this might be right for
Macular Degeneration
Genentech, Inc. 720
Testing effectiveness (Phase 2)UnknownNCT00809419
What this trial is testing

The NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy

Who this might be right for
Age Related Macular Degeneration
NeoVista 32
Early research (Phase 1)Study completedNCT05953012
What this trial is testing

Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
PharmAbcine 17
Testing effectiveness (Phase 2)Looking for participantsNCT06458595
What this trial is testing

Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Age-related Macular Degeneration
Chengdu Origen Biotechnology Co., Ltd. 44
Not applicableLooking for participantsNCT06375239
What this trial is testing

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

Who this might be right for
Retinitis PigmentosaChoroideremiaStargardt Macular Dystrophy+4 more
Ray Therapeutics, Inc. 120
Not applicableUnknownNCT02960828
What this trial is testing

"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study

Who this might be right for
Age-Related Macular DegenerationRetinal Drusen
Seoul National University Bundang Hospital 21
Not applicableLooking for participantsNCT07255859
What this trial is testing

AVIGA3 (Cohort 2.0)

Who this might be right for
Maculopathy
Tan Tock Seng Hospital 60
Not applicableStudy completedNCT05287269
What this trial is testing

Ocular Coherence Tomography During Cataract Assessment

Who this might be right for
Cataract SenileMacula HoleEpiretinal Membrane+2 more
Brighton and Sussex University Hospitals NHS Trust 626
Post-approval studies (Phase 4)Study completedNCT00135837
What this trial is testing

Photodynamic Therapy in Occult-Only Lesions (POOL)

Who this might be right for
Age-Related Macular Degeneration
Novartis 202
Not applicableStudy completedNCT06723288
What this trial is testing

A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 736
Early research (Phase 1)Study completedNCT00018070
What this trial is testing

Identification and Treatment of Feeder Vessels in Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 20
Large-scale testing (Phase 3)Looking for participantsNCT07440225
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Early research (Phase 1)Study completedNCT00001615
What this trial is testing

Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
National Eye Institute (NEI) 180
Testing effectiveness (Phase 2)Study completedNCT02181517
What this trial is testing

Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 25
Large-scale testing (Phase 3)Looking for participantsNCT07614776
What this trial is testing

Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationnAMD
Amgen 304
Early research (Phase 1)Study completedNCT02332941
What this trial is testing

Treatment -Resistant Neovascular Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Washington University School of Medicine 5
Next Page